R
Raffaella Origa
Researcher at University of Cagliari
Publications - 98
Citations - 3993
Raffaella Origa is an academic researcher from University of Cagliari. The author has contributed to research in topics: Thalassemia & Deferasirox. The author has an hindex of 25, co-authored 85 publications receiving 3406 citations.
Papers
More filters
Interim results from a phase 2a, open-label, dose-finding study to determine the safety, efficacy, and tolerability of sotatercept (ace-011) in adults with beta-thalassemia
John B. Porter,Cappellini,Raffaella Origa,G. L. Forni,A. Laadem,F Galacteros,E Voskaridou,D Miteva,Sung,Rajesh Chopra,Jean-Benoît Arlet,Jean-Antoine Ribeil,K Klesczewski,K Attie,Maciej W Garbowski,G Graziadei,M Balocco,Olivier Hermine +17 more
Journal ArticleDOI
Current growth patterns in children and adolescents with thalassemia major
Raffaella Origa,Fabrice Danjou,Valeria Orecchia,Antonietta Zappu,Carlo Dessì,Maria Loreta Foschini,Giovan Battista Leoni,Paolo Moi,Maddalena Morittu,Anna Demurtas,Sandro Loche +10 more
TL;DR: Although the cause of short stature in children with thalassemia major is not well understood, it is believed to be multifactorial and many different factors including iron overload, intensive use of iron chelators, and gonadal damage may interact.
Journal ArticleDOI
Changes in HbA2 and HbF in alpha thalassemia carriers with KLF1 mutation
Stefania Satta,Maria Elisabetta Paglietti,Maria Carla Sollaino,Susanna Barella,Paolo Moi,Maria Franca Desogus,Franca Rosa Demartis,Laura Manunza,Raffaella Origa +8 more
TL;DR: It is found that KLF1 mutations modulate the phenotype in a cohort of α-thalassemia carriers, and these mutations trigger a series of benign human red blood phenotypes, such as an increase in HbA2 and HBF.
Journal ArticleDOI
EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
Nienke Schotten,Coby M. Laarakkers,Rian Roelofs,Raffaella Origa,van Kraaij Mg,Dorine W. Swinkels +5 more
TL;DR: This work has shown that MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance, and that these mutations are most common in patients with myelodysplastic syndromes.
Journal ArticleDOI
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization.
Valeria Pinto,Khaled M. Musallam,Giorgio Derchi,Giovanna Graziadei,Marianna Giuditta,Raffaella Origa,Susanna Barella,Gavino Casu,Annamaria Pasanisi,Filomena Longo,Maddalena Casale,Robeta Miceli,Pierluigi Merella,Immacolata Tartaglione,Antonio Piga,Maria Domenica Cappellini,Barbara Gianesin,Gian Luca Forni +17 more
TL;DR: Pinto et al. as discussed by the authors analyzed the outcome of 24 patients with pulmonary arterial hypertension documented by right heart catheterization, and they reported that with a median follow-up of 4 years, 54% died, most of which deaths were attributable to PAH.